Delivery Order SPE2DB20D3104-SPE2DB25FW0A0
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Spiriva Respimat 2.5 mcg inhalation medication in 4-gram quantities, with a ceiling value of $1,277.09. This firm fixed-price delivery order, which must be completed by August 15, 2025, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,322.94 to AmerisourceBergen Drug Corp for Spiriva Respimat 1.25 mcg inhaler (4 grams) on August 13, 2025, with completion scheduled for August 14, 2025. This firm fixed price delivery order represents a non-competitive set-aside procurement and reflects AmerisourceBergen's role as a critical pharmaceutical supplier within the federal medical supply chain. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a $4,865.00 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Spiriva Respimat 2.5 mcg inhalation medication in 4 gram quantities. This firm fixed-price contract, with an ultimate completion date of August 5, 2025, represents a competitively awarded, non-set-aside procurement executed through AmerisourceBergen's existing relationship with DLA. The pharmaceutical product will be delivered to the company's corporate office...
- The Defense Logistics Agency awarded a $1,318.54 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Spiriva Respimat 2.5 mcg inhaler cartridges (4 grams). This firm fixed-price delivery order, which is not set-aside, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 4, 2025. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical...
- On August 18, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $1,188.66 to AmerisourceBergen Drug Corp for Spiriva Respimat 2.5 mcg inhalation solution (4 gm). This firm fixed-price contract, with an ultimate completion date of August 19, 2025, is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's capability to compete for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Spiriva Respimat 1.25 mcg inhalation solution (4 grams) with a ceiling value of $1,861.59. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 25, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $5,790.98 to AmerisourceBergen Drug Corp for the supply of Spiriva Respimat 2.5 mcg inhalation medication in 4 gram quantities. This is a firm fixed price, non-set-aside contract with an ultimate completion date of July 22, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $2,088.20 to AmerisourceBergen Drug Corp for Spiriva Respimat 2.5 micrograms inhaler (4 grams) on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Spiriva Respimat is a prescription maintenance bronchodilator commonly used in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for SPIRIVA RESPIMAT 2.5 MCG inhalation medication in a 4 GM formulation, with a ceiling value of $1,779.64. This competitively awarded, firm fixed-price delivery order was issued on July 29, 2025, with an ultimate completion date of July 30, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Spiriva Respimat 2.5 mcg inhalation medication in 4 gm units. This firm fixed price delivery order, valued at $2,640.52, is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The order is scheduled for completion by September 5, 2025, with performance at the company's...
- SPE2DB20D3104Indefinite Delivery Contract
- SPE2DB20D3104-SPE2DB25FW0A0Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Spiriva Respimat 2.5 mcg inhalation medication in a 4-gram formulation. This competitively awarded, non-set-aside contract carries a ceiling value of $2,680.75 and a firm fixed price structure, with an ultimate completion date of September 9, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal medical supplier, AmerisourceBergen Drug Corp leverages this comprehensive vehicle to supply a wide range of pharmaceuticals and medical supplies to support military healthcare programs globally, including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's ability to fulfill this order demonstrates its continued capability to meet federal procurement requirements for specialized respiratory medications supporting military personnel and veteran healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 9/8/25 |